Tilray Brands (TLRY) Equity Income (2020)

Tilray Brands' (TLRY) quarterly Equity Income came in at -$3.5 million in Q1 2020.

Tilray Brands (TLRY) Equity Income (2020) Analysis & Trends

Tilray Brands (TLRY) has 1 years of Equity Income data on file, last reported at -$3.5 million in Q1 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Equity Income (Qtr)
1	Haleon	43.85 Bn	42.88 Bn	-	-
2	Teva Pharmaceutical Industries	43.02 Bn	39.37 Bn	2.15 Bn	-500,000.00
3	Zoetis	31.47 Bn	29.79 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.59 Bn	22.79 Bn	5.10 Bn	3.38 Mn
5	United Therapeutics	22.20 Bn	19.53 Bn	683.80 Mn	-
6	Viatris	18.76 Bn	17.87 Bn	1.46 Bn	-
7	Neurocrine Biosciences	15.45 Bn	15.06 Bn	935.80 Mn	-
8	Elanco Animal Health	11.76 Bn	11.23 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.10 Bn	9.94 Bn	-	-
10	Tilray Brands	519.72 Mn	285.09 Mn	90.52 Mn	-

Download Data

Date	Value
Mar 31, 2020	-3.50 Mn